CLINICAL TRIALS PROFILE FOR CLINOLIPID 20%
✉ Email this page to a colleague
All Clinical Trials for Clinolipid 20%
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT02476994 ↗ | Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion | Terminated | Baxter Healthcare Corporation | Phase 4 | 2015-05-01 | This will be a descriptive study designed to evaluate the propensity for hospitalized pediatric patients treated adequately with Clinolipid or standard of care for up to 90 days to develop Essential Fatty Acid Deficiency (EFAD). Additionally, this study design will evaluate the safety and efficacy of using Clinolipid in a pediatric population. |
| NCT04555044 ↗ | Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A) | Recruiting | Baxter Healthcare Corporation | Phase 4 | 2021-01-22 | This will be a descriptive study designed to evaluate the propensity for hospitalized pediatric patients treated adequately with Clinolipid or standard of care (Intralipid) from 7 up to 90 days to develop Essential Fatty Acid Deficiency (EFAD). Additionally, this study design will evaluate the safety and efficacy of using Clinolipid or Intralipid in a pediatric population. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Clinolipid 20%
Condition Name
Clinical Trial Locations for Clinolipid 20%
Trials by Country
Clinical Trial Progress for Clinolipid 20%
Clinical Trial Phase
Clinical Trial Sponsors for Clinolipid 20%
Sponsor Name
